Bare metal stent thrombosis in patients with acute coronary syndrome-Incidence and predictors-

Circulation Journal

Volumn 76, Issue 3, 2012, Pages 634-640

  Zghal, Fathia Mghaieth ^a,b   Amri, Aymen ^a   Mourali, Mohamed Sami ^a,b   Farhati, Abdeljelil ^a   Larbi, Noureddine ^a,b   Mechmèche, Rachid ^a,b  

^a LA RABTA HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Acute coronary syndrome; Percutaneous coronary intervention; Stents; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CLOPIDOGREL;

ACUTE CORONARY SYNDROME; ADULT; AGE; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; BARE METAL STENT; BLOOD FLOW; BLOOD VESSEL DIAMETER; COHORT ANALYSIS; DRUG WITHDRAWAL; FEMALE; FEVER; FLOW RATE; FOLLOW UP; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THROMBUS;

ACUTE CORONARY SYNDROME; ADULT; AGED; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; STENTS; THROMBOSIS; TICLOPIDINE;

EID: 84857513333     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.cj-11-1041     Document Type: Article

References (37)

1. Tolleson TR, Newby LK, Harrington RA, Bhapkar MV, Verheugt FW, Berger PB, et al. Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials). Am J Cardiol 2003; 92: 330-333.
2. Aoki J, Lansky AJ, Mehran R, Moses J, Bertrand ME, McLaurin BT, et al. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: The Acute Catheterization and Urgent Intervention Triage Strategy Trial. Circulation 2009; 119: 687-698.
3. Beinart R, Abu Sham R, Segev A, Hod H, Guetta V, Shechter M, et al. The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome. Am Heart J 2010; 159: 118-124.
4. Mahmoudi M, Delhaye C, Waksman R. Safety and efficacy of drugeluting stents and bare metal stents in acute coronary syndrome. Cardiovasc Revasc Med 2011; 12: 385-390.
5. Inoue K. Drug-eluting stents are not indicated for patients with acute coronary syndrome: Should drug-eluting stents be indicated for patients with acute coronary syndrome? (Con) Circ J 2010; 74: 2232-2238.
6. Nakagawa Y. What is the effectiveness of drug-eluting stents in the treatment of ST-elevation myocardial infarction?: Should drug-eluting stents be indicated for patients with acute coronary syndrome? (Pro) Circ J 2010; 74: 2225-2231.
7. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Van Es GA, et al; Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
8. Smith SC, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, et al. ACC/AHA guidelines for percutaneous coronary intervention: Executive summary: A report of the American College of Cardiology/ American Heart Association task force on practice guidelines endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001; 103: 3019-3041.
9. The TIMI, Study Group. The thrombolysis in myocardial infarction (TIMI) trial: Phase I findings. N Engl J Med 1985; 312: 932-936.
10. Lagerqvist B, Carlsson J, Fröbert O, Lindbäck J, Scherstén F, Stenestrand U, et al; Swedish Coronary Angiography and Angioplasty Registry Study Group. Stent thrombosis in Sweden: A report from the Swedish Coronary Angiography and Angioplasty Registry. Circ Cardiovasc Interv 2009; 2: 401-408.
11. Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, et al. Stent thrombosis, myocardial infarction, and death after drugeluting and bare-metal stent coronary interventions. J Am Coll Cardiol 2007; 50: 463-470.
12. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 667-678.
13. de la Torre-Hernández JM, Alfonso F, Hernández F, Elizaga J, Sanmartin M, Pinar E, et al; ESTROFA Study Group. Drug-eluting stent thrombosis: Results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol 2008; 51: 986-990.
14. de la Torre Hernández JM, Alfonso F, Gimeno F, Diarte JA, Lopez-Palop R, Pérez de Prado A, et al; ESTROFA-2 Study Group. Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion- 2). JACC Cardiovasc Interv 2010; 3: 911-919.
15. Lotan C, Meredith IT, Mauri L, Liu M, Rothman MT; E-Five Investigators. Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the EFive registry. JACC Cardiovasc Interv 2009; 2: 1227-1235.
16. Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JPR, et al.; for the TRITON-TIMI 38 Investigators. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITONTIMI 38 trial: A subanalysis of a randomised trial. Lancet 2008; 371: 1353-1363.
17. Kukreja N, Onuma Y, Garcia-Garcia HM, Daemen J, van Domburg R, Serruys PW Interventional Cardiologists of the Thoraxcenter (2000- 2005). The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. JACC Cardiovasc Interv 2009; 2: 534-541.
18. Dangas GD, Caixeta A, Mehran R, Parise H, Lansky AJ, Cristea E, et al; Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Investigators. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation 2011; 123: 1745-1756.
19. Tebaldi M, Arcozzi C, Campo G, Percoco G, Ferrari R, Valgimigli M; STRATEGY Investigators. The 5-year clinical outcomes after a randomized comparison of sirolimus-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2009; 54: 1900-1901.
20. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrié D, et al; TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006; 355: 1093-1104.
21. Park KW, Kang SH, Chung WY, Lee HY, Park JS, Kang HJ, et al. 'Real world' comparison of drug-eluting stents vs bare metal stents in the treatment of unselected patients with acute ST-segment elevation myocardial infarction. Circ J 2010; 74: 1111-1120.
22. Li Y, Torguson R, Syed AI, Ben-Dor I, Collins SD, Maluenda G, et al. Effect of drug-eluting stents on frequency of repeat revascularization in patients with unstable angina pectoris or non-ST-elevation myocardial infarction. Am J Cardiol 2009; 104: 1654-1659.
23. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 2004; 109: 881-886.
24. Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, van Domburg RT, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: The importance of thrombus burden. J Am Coll Cardiol 2007; 50: 573-583.
25. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-1971.
26. Nath CF, Moller DWM, Ellis SG, Rosenschein U, Chapekis A, Quain L, et al. Thrombosis of a flexible coil coronary stent: Frequency, predictors and clinical outcome. J Am Coll Cardiol 1993; 21: 622-627.
27. Park DW, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, et al. Creactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation. Circulation 2009; 120: 1987-1995.
28. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, et al. Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. Eur Heart J 2008; 29: 1241-1249.
29. Yu H, Rifai N. High-sensitivity C-reactive protein and atherosclerosis: From theory to therapy. Clin Biochem 2000; 33: 601-610.
30. Bickel C, Rupprecht HJ, Blankenberg S, Espiniola-Klein C, Schlitt A, Rippin G, et al; AtheroGene Investigators. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002; 89: 901-908.
31. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
32. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113: 1108-1113.
33. van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, et al. Predictors of coronary stent thrombosis: The Dutch Stent Thrombosis Registry. J Am Coll Cardiol 2009; 53: 1399-1409.
34. Machecourt J, Danchin N, Lablanche JM, Fauvel JM, Bonnet JL, Marliere S, et al; EVASTENT Investigators. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: The EVASTENT Matched-Cohort Registry. J Am Coll Cardiol 2007; 50: 501-508.
35. Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, et al. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction. Am Heart J 2009; 157: 688-694.
36. Lemesle G, Pinto Slottow TL, Waksman R. Very late stent thrombosis after bare-metal stent implantation: Case reports and review of the literature. J Invasive Cardiol 2009; 21: e27-e32.
37. Sanchez RA, Gonzalez OE, Martin RR, Jimenez VS, Galeote G, Calvo L, et al. Intravascular ultrasound and histology findings in very late bare-metal stent thrombosis. Rev Esp Cardiol 2010; 63: 1492-1496.